{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:51:59Z","timestamp":1794304319281,"version":"4.9.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Center Research and Development Fund","award":["28-A-16"],"award-info":[{"award-number":["28-A-16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1245\/s10434-019-07297-9","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T11:43:09Z","timestamp":1552477389000},"page":"1669-1675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Defining Tumor Rupture in Gastrointestinal Stromal Tumor"],"prefix":"10.1245","volume":"26","author":[{"given":"Toshirou","family":"Nishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toto","family":"H\u00f8lmebakk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrajit P.","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"Suppl 4","key":"7297_CR1","doi-asserted-by":"publisher","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","volume":"29","author":"PG Casali","year":"2018","unstructured":"Casali PG, Abecassis N, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29 Suppl 4:iv51\u2013iv67.","journal-title":"Ann Oncol."},{"key":"7297_CR2","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/cncr.10492","volume":"94","author":"C Wittekind","year":"2002","unstructured":"Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94: 2511\u201316.","journal-title":"Cancer"},{"key":"7297_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003086-198011000-00013","volume":"153","author":"WF Enneking","year":"1980","unstructured":"Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106\u201320.","journal-title":"Clin Orthop Relat Res"},{"key":"7297_CR4","volume-title":"TNM Classification of Malignant Tumors (UICC)","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumors (UICC). 8th ed. Wiley: Oxford; 2017.","edition":"8"},{"key":"7297_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/hupa.2002.123545","volume":"33","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459\u201365.","journal-title":"Hum Pathol."},{"key":"7297_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","volume":"23","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70\u201383.","journal-title":"Semin Diagn Pathol."},{"key":"7297_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1470-2045(09)70242-6","volume":"10","author":"JS Gold","year":"2009","unstructured":"Gold JS, G\u00f6nen M, Guti\u00e9rrez A, et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 2009;10:1045\u201352.","journal-title":"Lancet Oncol."},{"key":"7297_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","volume":"13","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Vehtari A, Riihim\u00e4ki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13:265\u201374.","journal-title":"Lancet Oncol."},{"key":"7297_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00000658-199201000-00010","volume":"215","author":"EH Ng","year":"1992","unstructured":"Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg. 1992;215:68\u201377.","journal-title":"Ann Surg."},{"key":"7297_CR10","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1245\/s10434-007-9377-9","volume":"14","author":"P Rutkowski","year":"2007","unstructured":"Rutkowski P, Nowecki ZI, Michej W, et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol 2007;14:2018\u201327.","journal-title":"Ann Surg Oncol"},{"key":"7297_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10147-007-0705-7","volume":"12","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Nakajima K, Nishitani A, et al. An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors. Int J Clin Oncol 2007;12:369\u201374.","journal-title":"Int J Clin Oncol"},{"key":"7297_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10120-014-0386-7","volume":"18","author":"Y Yanagimoto","year":"2015","unstructured":"Yanagimoto Y, Takahashi T, Muguruma K, et al. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy. Gastric Cancer. 2015;18:426\u201333.","journal-title":"Gastric Cancer."},{"key":"7297_CR13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/bjs.10104","volume":"103","author":"T H\u00f8lmebakk","year":"2016","unstructured":"H\u00f8lmebakk T, Bjerkehagen B, Boye K, et al. Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine. Br J Surg. 2016;103:684\u201391.","journal-title":"Br J Surg."},{"key":"7297_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1245\/s10434-018-6353-5","volume":"25","author":"T H\u00f8lmebakk","year":"2018","unstructured":"H\u00f8lmebakk T, Hompland I, Bjerkehagen B, et al. Recurrence-free survival after resection of gastric gastrointestinal stromal tumors classified according to a strict definition of tumor rupture: a population-based study. Ann Surg Oncol. 2018;25:1133\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"7297_CR15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1245\/s10434-018-6505-7","volume":"25","author":"T Nishida","year":"2018","unstructured":"Nishida T, Cho H, Hirota S, et al. Clinicopathological features and prognosis of primary gists with tumor rupture in the real world. Ann Surg Oncol. 2018;25(7):1961\u20139.","journal-title":"Ann Surg Oncol."},{"key":"7297_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ejso.2011.06.005","volume":"37","author":"P Rutkowski","year":"2011","unstructured":"Rutkowski P, Bylina E, Wozniak A, et al. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour: the impact of tumour rupture on patient outcomes. Eur J Surg Oncol. 2011;37:890\u20136.","journal-title":"Eur J Surg Oncol."},{"key":"7297_CR17","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1158\/1078-0432.CCR-14-1677","volume":"20","author":"A Wozniak","year":"2014","unstructured":"Wozniak A, Rutkowski P, Sch\u00f6ffski P, et al. Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a European multicenter analysis based on ConticaGIST. Clin Cancer Res. 2014;20:6105\u201316.","journal-title":"Clin Cancer Res."},{"key":"7297_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jamasurg.2014.2881","volume":"150","author":"DA Bischof","year":"2015","unstructured":"Bischof DA, Kim Y, Dodson R, et al. Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA Surg. 2015;150:299\u2013306.","journal-title":"JAMA Surg."},{"key":"7297_CR19","doi-asserted-by":"publisher","first-page":"e1526","DOI":"10.1097\/MD.0000000000001526","volume":"94","author":"MC Kim","year":"2015","unstructured":"Kim MC, Yook JH, Yang HK, et al. Long-term surgical outcome of 1057 gastric GISTs according to 7th UICC\/AJCC TNM system: multicenter observational study from Korea and Japan. Medicine (Baltimore). 2015;94:e1526.","journal-title":"Medicine (Baltimore)."},{"key":"7297_CR20","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/bjs.7222","volume":"97","author":"P Hohenberger","year":"2010","unstructured":"Hohenberger P, Ronellenfitsch U, Oladeji O, et al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg. 2010;97:1854\u20139.","journal-title":"Br J Surg."},{"key":"7297_CR21","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/cncr.28669","volume":"120","author":"H Joensuu","year":"2014","unstructured":"Joensuu H, Eriksson M, Hall KS, et al. Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib. Cancer. 2014;120:2325\u201333.","journal-title":"Cancer."},{"key":"7297_CR22","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1002\/bjs.10743","volume":"105","author":"K Boye","year":"2018","unstructured":"Boye K, Berner JM, Hompland I, et al. Genotype and risk of tumour rupture in gastrointestinal stromal tumour. Br J Surg. 2018;105:e169\u2013e175.","journal-title":"Br J Surg."},{"key":"7297_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s10147-008-0798-7","volume":"13","author":"T Nishida","year":"2008","unstructured":"Nishida T, Hirota S, Yanagisawa A, et al. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan. Int J Clin Oncol. 2008;13:416\u201330.","journal-title":"Int J Clin Oncol."},{"issue":"Suppl 2","key":"7297_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2010.0116","volume":"8","author":"GD Demetri","year":"2010","unstructured":"Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8 Suppl 2:S1\u201341.","journal-title":"J Natl Compr Canc Netw."},{"key":"7297_CR25","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1200\/JCO.2015.62.4304","volume":"33","author":"PG Casali","year":"2015","unstructured":"Casali PG, Le Cesne A, Poveda Velasco A, et al. Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with Imatinib as an adjuvant: a European Organisation for Research and treatment of cancer soft tissue and bone Sarcoma Group Intergroup randomized trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. J Clin Oncol. 2015;33:4276\u201383.","journal-title":"J Clin Oncol."},{"key":"7297_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.2012.347","volume":"307","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307:1265\u201372.","journal-title":"JAMA."},{"key":"7297_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s101200300005","volume":"6","author":"Y Fujimoto","year":"2003","unstructured":"Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer. 2003;6:39\u201348.","journal-title":"Gastric Cancer."},{"key":"7297_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2016.02.021","volume":"59","author":"M Eriksson","year":"2016","unstructured":"Eriksson M, Reichardt P, Hall KS, et al. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour: does it increase the risk for tumour cell seeding and recurrence? Eur J Cancer 2016; 59: 128\u201333.","journal-title":"Eur J Cancer"},{"key":"7297_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jamcollsurg.2012.05.008","volume":"215","author":"MD McCarter","year":"2012","unstructured":"McCarter MD, Antonescu CR, Ballman KV, et al. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg 2012; 215: 53\u20139.","journal-title":"J Am Coll Surg"},{"key":"7297_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2012.09.004","volume":"39","author":"R Tielen","year":"2013","unstructured":"Tielen R, Verhoef C, van Coevorden F, et al. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Eur J Surg Oncol 2013;39:150\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"7297_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2015.62.9170","volume":"34","author":"H Joensuu","year":"2016","unstructured":"Joensuu H, Eriksson M, Hall KS, et al. Adjuvant imatinib for high-risk GI stromal tumor: analysis of a randomized trial. J Clin Oncol. 2016;34:244\u201350.","journal-title":"J Clin Oncol."},{"key":"7297_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00268-011-0995-9","volume":"35","author":"Y Chen","year":"2011","unstructured":"Chen Y, Hao J, Yang Y, et al. Tumor rupture predicts early metastasis and poor prognosis in stage III soft tissue sarcomas. World J Surg. 2011;35:1002\u20139.","journal-title":"World J Surg."},{"key":"7297_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1245\/s10434-016-5462-2","volume":"24","author":"S Bonvalot","year":"2017","unstructured":"Bonvalot S, Levy A, Terrier P, et al. Primary extremity soft tissue sarcomas: does local control impact survival? Ann Surg Oncol. 2017;24:194\u2013201.","journal-title":"Ann Surg Oncol."},{"key":"7297_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s11999-012-2592-0","volume":"471","author":"P Rutkowski","year":"2013","unstructured":"Rutkowski P, Trepka S, Ptaszynski K, et al. Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall. Clin Orthop Relat Res. 2013;471:860\u201370.","journal-title":"Clin Orthop Relat Res."},{"key":"7297_CR35","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1634\/theoncologist.2016-0498","volume":"22","author":"K Harati","year":"2017","unstructured":"Harati K, Goertz O, Pieper A, et al. Soft tissue sarcomas of the extremities: surgical margins can be close as long as the resected tumor has no ink on it. Oncologist. 2017;22:1400\u201310.","journal-title":"Oncologist."},{"key":"7297_CR36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","volume":"263","author":"A Gronchi","year":"2016","unstructured":"Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016;263:1002\u20139.","journal-title":"Ann Surg."},{"key":"7297_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/jso.24919","volume":"117","author":"M Fairweather","year":"2018","unstructured":"Fairweather M, Gonzalez RJ, Strauss D, Raut CP. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018;117:33\u201341","journal-title":"J Surg Oncol."},{"key":"7297_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12306-017-0475-y","volume":"101","author":"G Bianchi","year":"2017","unstructured":"Bianchi G, Sambri A, Cammelli S, et al. Impact of residual disease after \u201cunplanned excision\u201d of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution. Musculoskelet Surg. 2017;101:243\u20138.","journal-title":"Musculoskelet Surg."},{"key":"7297_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/annonc\/mdt577","volume":"25","author":"M Toulmonde","year":"2014","unstructured":"Toulmonde M, Bonvalot S, M\u00e9eus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014;25:735\u201342.","journal-title":"Ann Oncol."},{"key":"7297_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","volume":"27","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31\u20137.","journal-title":"J Clin Oncol."},{"key":"7297_CR41","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1245\/s10434-014-3855-7","volume":"21","author":"CE Mussi","year":"2014","unstructured":"Mussi CE, Daolio P, Cimino M, et al. Atypical lipomatous tumors: should they be treated like other sarcoma or not? Surgical consideration from a bi-institutional experience. Ann Surg Oncol. 2014;21:4090\u20137.","journal-title":"Ann Surg Oncol."},{"key":"7297_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.gore.2018.01.007","volume":"23","author":"F Raspagliesi","year":"2018","unstructured":"Raspagliesi F, Bogani G, Lorusso D. The impact of morcellation on survival outcomes of undiagnosed uterine sarcoma. Gynecol Oncol Rep. 2018;23:37\u20138.","journal-title":"Gynecol Oncol Rep."},{"issue":"8","key":"7297_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jogoh.2018.05.015","volume":"47","author":"M Rousseau","year":"2018","unstructured":"Rousseau M, Morel A, Dechoux S, et al. Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018. J Gynecol Obstet Hum Reprod. 2018;47(8):341\u20139.","journal-title":"J Gynecol Obstet Hum Reprod."},{"key":"7297_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","volume":"144","author":"F Raspagliesi","year":"2017","unstructured":"Raspagliesi F, Maltese G, Bogani G, et al. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study. Gynecol Oncol. 2017;144:90\u20135.","journal-title":"Gynecol Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07297-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:32:31Z","timestamp":1663083151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07297-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["7297"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07297-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}